Abstract

We’d like to develop the statistical machinery to infer the difference between the mutational profiles across different categories and associate the variations with the know exposures. This tool is potentially useful for identifying novel and existing mutational processes and correlating them with risk factors in which later can be used to monitor any treatment effects in personalized medicine and targeted therapy.